Soma is a brand name of carisoprodol, approved by the FDA in the following formulation(s):
SOMA (carisoprodol - tablet; oral)
Manufacturer: MEDA PHARMS
Approved Prior to Jan 1, 1982
Strength(s): 350MG [AA]
Manufacturer: MEDA PHARMS
Approval date: September 13, 2007
Strength(s): 250MG [RLD]
Has a generic version of Soma been approved?
A generic version of Soma has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Soma and have been approved by the FDA:
carisoprodol tablet; oral
Manufacturer: ADVENT PHARMS
Approval date: June 7, 2005
Strength(s): 350MG [AA]
Manufacturer: AUROBINDO PHARMA
Approval date: August 6, 2009
Strength(s): 350MG [AA]
Manufacturer: COREPHARMA
Approval date: September 21, 2000
Strength(s): 350MG [AA]
Manufacturer: MIRROR PHARMS
Approval date: October 22, 2008
Strength(s): 350MG [AA]
Manufacturer: MUTUAL PHARM
Approval date: October 17, 1991
Strength(s): 350MG [AA]
Manufacturer: PROSAM LABS
Approval date: March 7, 1997
Strength(s): 350MG [AA]
Manufacturer: SUN PHARM INDS LTD
Approval date: February 27, 2007
Strength(s): 350MG [AA]
Manufacturer: VINTAGE PHARMS
Approval date: September 8, 1997
Strength(s): 350MG [AA]
Manufacturer: WATSON LABS
Approval date: April 20, 1982
Strength(s): 350MG [AA]
Manufacturer: WEST WARD
Approval date: January 24, 1996
Strength(s): 350MG [AA]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Soma. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Soma.
Related Exclusivities
Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.
See also...
- Soma Consumer Information (Drugs.com)
- Soma Consumer Information (Wolters Kluwer)
- Soma Consumer Information (Cerner Multum)
- Soma Advanced Consumer Information (Micromedex)
- Carisoprodol Consumer Information (Drugs.com)
- Carisoprodol Consumer Information (Wolters Kluwer)
- Carisoprodol Consumer Information (Cerner Multum)
- Carisoprodol Advanced Consumer Information (Micromedex)
- Carisoprodol AHFS DI Monographs (ASHP)